Vaccines
Total Trials
42
As Lead Sponsor
36
As Collaborator
6
Total Enrollment
71,168
NCT04313127
Phase I Clinical Trial of a COVID-19 Vaccine in 18-60 Healthy Adults
Phase: Phase 1
Role: Lead Sponsor
Start: Mar 16, 2020
Completion: Feb 20, 2021
NCT04087460
Phase Ⅰa Clinical Trial of a Pneumococcal Vaccine
Phase: Early Phase 1
Start: Apr 10, 2020
Completion: Jun 30, 2022
NCT04341389
A Phase II Clinical Trial to Evaluate the Recombinant Vaccine for COVID-19 (Adenovirus Vector)
Phase: Phase 2
Role: Collaborator
Start: Apr 12, 2020
Completion: Dec 31, 2020
NCT04099303
Phase I Clinical Trial of Diphtheria, Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed .
Start: Apr 28, 2020
Completion: Nov 25, 2021
NCT04100772
Phase I Clinical Trial of a Candidate PCV13 in Healthy People Aged 6 Weeks and Above
Start: May 18, 2020
Completion: Aug 23, 2022
NCT04398147
Phase I/II Clinical Trial of Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) in Canada
Phase: Phase 1/2
Start: Aug 1, 2020
Completion: Dec 30, 2021
NCT04540419
Clinical Trial of Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) Against COVID-19
Phase: Phase 3
Start: Sep 11, 2020
Completion: Jul 30, 2021
NCT04526990
Phase III Trial of A COVID-19 Vaccine of Adenovirus Vector in Adults 18 Years Old and Above
Start: Sep 15, 2020
Completion: Oct 21, 2022
NCT04566770
A Clinical Trial of A COVID-19 Vaccine Named Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector)
Start: Sep 24, 2020
Completion: Jan 19, 2022
NCT04841369
Phase III Clinical Trial of a Candidate PCV13 in Healthy People Aged 6 Weeks and Above (PICTPCV13i)
Start: Apr 13, 2021
Completion: Sep 20, 2022
NCT04840992
Phase I/II Clinical Trial of Recombinant Novel Coronavirus (COVID-19) Vaccine (Adenovirus Type 5 Vector) for Inhalation
Start: Apr 21, 2021
Completion: Aug 9, 2022
NCT04892459
Study on Sequential Immunization of Inactivated SARS-CoV-2 Vaccine and Recombinant SARS-CoV-2 Vaccine (Ad5 Vector)
Phase: Phase 4
Start: May 25, 2021
Completion: Dec 25, 2021
NCT04916886
A Clinical Trial of Immunobridging and Lot-to-lot Consistency of COVID-19 Vaccine (Ad5-nCoV) in Different Age Groups.
Phase: N/A
Start: Jun 3, 2021
Completion: Jul 31, 2022
NCT05005156
Phase IIb Trial of Recombinant Novel Coronavirus Vaccine (Ad5-nCoV) in Adults 18 Years of Age and Older, Living With HIV
Start: Jun 24, 2021
Completion: Jan 13, 2023
NCT04952727
Study on Sequential Immunization of Inactivated COVID-19 Vaccine and Recombinant COVID-19 Vaccine (Ad5 Vector) in Elderly Adults
Start: Aug 26, 2021
Completion: May 15, 2022
NCT05293223
Phase IIB Study of Recombinant Novel Coronavirus Vaccine
Start: Oct 1, 2021
Completion: Dec 15, 2023
NCT05124561
Study to Evaluate the inHaled Recombinant COVID-19 Vaccine (Adenovirus Type 5 Vector) On the Protective-Efficacy in Adults (SeiHOPE)
Start: Dec 15, 2021
Completion: Aug 20, 2022
NCT05169008
A Study to Evaluate the Safety and Immunogenicity of Ad5-nCoV and Ad5-nCoV-IH in CoronaVac Immunized Children and Adolescents
Start: Feb 25, 2022
NCT05373485
Phase I Clinical Trial of COVID-19 mRNA Vaccine in Adults Aged 18 Years and Older
Start: May 17, 2022
Completion: Aug 8, 2022
NCT05373472
Phase II Clinical Trial of COVID-19 mRNA Vaccine in Adults Aged 18 Years and Older
Start: Jul 6, 2022
Completion: Sep 21, 2022
NCT05517642
IH Convidecia as Second Booster Dose Against Breakthrough Infections
Start: Sep 20, 2022
Completion: May 2, 2023
NCT05442684
A Study to Evaluate the Safety and Immunogenicity of Ad5-vector Based Vaccine Against Coronavirus Variants in Adults (≥18 Years) Immunized With 2 Doses of mRNA Vaccines Plus One Dose of Booster AZD1222 Vaccine
Start: Nov 30, 2022
Completion: Jun 30, 2023
NCT05622942
Clinical Trial of Recombinant Pneumococcal Protein Vaccine
Start: Mar 11, 2023
Completion: Jan 30, 2024
NCT05951725
A Clinical Trial of Diphtheria, Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed(DTcP)
Start: Aug 11, 2023
Completion: Apr 1, 2025
NCT06011200
A Clinical Trial of ACYW135 Group Meningococcal Polysaccharide Conjugate Vaccine (CRM197 Vector) in a 4 to 6 Year-old Population
Start: Sep 16, 2023
Completion: May 11, 2024
NCT05935176
Phase IV Clinical Study of Immunogenicity of ACYW135 Group Meningococcal Polysaccharide Conjugate Vaccine (CRM197 Vector)
Start: Sep 20, 2023
Completion: Jan 8, 2025
NCT05991427
A Study to Evaluate the Safety and Immunogenicity of ChAdOx1-VZV in Healthy Adults Aged 50-65 Years
Start: Nov 7, 2023
Completion: Nov 4, 2024
NCT06056050
A Clinical Trial of Adsorbed Cell-free DPT Vaccine (5-component) (for People Aged 6 Years and Above)
Start: Dec 6, 2023
Completion: Sep 28, 2025
NCT06123663
A Study to Evaluate the Safety and Immunogenicity of a Single Dose of Adsorbed Tetanus Vaccine in a Population Aged 18 Years and Over
Start: Dec 20, 2023
Completion: Jun 18, 2024
NCT06101173
A Study to Evaluate the Safety and Immunogenicity of Recombinant Trivalent Poliomyelitis Vaccine (Sf-RVN Cell) in Healthy Adults
Start: Jan 15, 2024
Completion: Sep 11, 2024
NCT06226714
A Clinical Trial of ACYW135 Group Meningococcal Polysaccharide Conjugate Vaccine (CRM197 Vector) in 18-59 Year Olds
Start: Mar 1, 2024
Completion: Aug 31, 2025
NCT06120751
A Clinical Trial to Evaluate the Safety and Immunogenicity of a Single Dose of Adsorbed Tetanus Vaccine in a Population Aged 18 Years and Over
Start: Mar 20, 2024
Completion: Sep 30, 2024
NCT06131554
A Clinical Trial to Evaluate the Immunogenicity and Safety of Group ACYW135 Meningococcal Conjugate Vaccine (CRM197) in Adults Aged 18 to 55 Years
Completion: Dec 31, 2025
NCT06389513
Clinical Study of the Safety of Menhycia® in 3-Month-Old Infants
Start: Jun 12, 2024
NCT06621654
Clinical Trial of Lyophilized Haemophilus Influenzae Type b Conjugate Vaccine
Start: Nov 15, 2024
Completion: Oct 31, 2026
NCT06700148
A Clinical Trial of ACYW135 Group Meningococcal Polysaccharide Conjugate Vaccine (CRM197 Vector) in 7 to 17 Year Olds
Start: Dec 14, 2024
Completion: Aug 30, 2025
NCT06577298
A Study to Evaluate the Safety and Immunogenicity of VLP-Polio in Infants and Toddlers
Start: Dec 19, 2024
Completion: Dec 31, 2026
NCT06708286
A Clinical Trials of Adsorbed Cell-free DPT Vaccine (Five-component)
Phase: Phase 2/3
Start: Dec 20, 2024
Completion: May 30, 2025
NCT06732583
A Study to Evaluate the Safety and Immunogenicity of Ad5-105K in Adults Aged 18 to 49 Years
Start: Feb 28, 2025
NCT06857370
Inter-lot Consistency Clinical Trial of Adsorbed Cell-free DTP (Three-component) Combined Vaccine
Start: Mar 23, 2025
Completion: Jan 31, 2026
NCT07017777
A Study to Evaluate the Immunogenicity and Safety of 13-valent Pneumococcal Conjugate Vaccine (PCV13i) in Healthy Infants Aged 2 Months (Minimum 6 Weeks)
Start: Oct 15, 2025
Completion: May 15, 2028
NCT07203755
Clinical Trial of the Adsorbed Acellular Pertussis (Tricomponent) DTaP-Haemophilus Influenzae Type b (Conjugate)-ACYW135 Group Meningococcal (Conjugate) Combined Vaccine
Start: Oct 22, 2025
Completion: Feb 28, 2029
Loading map...